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Trends in life expectancy and age-specific mortality in 
England and Wales, 1970–2016, in comparison with a 
set of 22 high-income countries: an analysis of vital 
statistics data
David A Leon, Dmitry A Jdanov, Vladimir M Shkolnikov
Summary
Background Since 2010, the rate of improvement in life expectancy in the UK has slowed. We aimed to put this trend 
in the context of changes over the long term and in relation to a group of other high-income countries.
Methods We compared sex-specific trends in life expectancy since 1970 and age-specific mortality in England and 
Wales with median values for 22 high-income countries (in western Europe, Australia, Canada, New Zealand, 
Japan, and the USA). We used annual mortality data (1970–2016) from the Human Mortality Database.
Findings Until 2011–16, male life expectancy in England and Wales followed the median life expectancy of the 
comparator group. By contrast, female life expectancy was below the median and is among the lowest of the countries 
considered. In 2011–16, the rate of improvement in life expectancy slowed sharply for both sexes in England and 
Wales, and slowed more moderately in the comparator group because of negative trends in all adult age groups. This 
deceleration resulted in a widening gap between England and Wales and the comparators from 2011 onwards. Since 
the mid-2000s, for the first time, mortality rates in England and Wales among people aged 25–50 years were 
appreciably higher than in the comparator group.
Interpretation Although many countries have seen slower increases in life expectancy since 2011, trends in England 
and Wales are among the worst. The poor performance of female life expectancy over the long-term is in part driven 
by the relative timing of the smoking epidemic across countries. The previously overlooked higher mortality among 
young working-age adults in England and Wales relative to other countries deserves urgent attention.
Funding None. 
Copyright © 2019 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 
4.0 license.
Introduction
For more than half a century, western European and 
other high-income countries have seen steady rises in 
life expectancy at birth.1 The reasons for this improvement 
include steps to control risk factors such as smoking and 
the adoption of increasingly effective treatments and 
screening programmes.2 However, fluctuations in the 
pace of mortality reduction are not uncommon and have 
been found in many high-income countries.3–5
Typically, a year in which life expectancy falls is followed 
by a rebound. An analysis reported declines in life 
expectancy (2014–15) in 11 of 18 high-income countries 
examined.6 Most of these showed a larger than average 
improvement in the subsequent period (2015–16). However, 
the UK and the USA were exceptions in that neither 
showed the expected recovery. Indeed, since 2010 the UK 
and each of its constituent countries7 have had smaller 
increases in life expectancy than have been previously 
recorded,5 with no change at all between 2016 and 2017.8
This plateauing of life expectancy in the UK has 
received attention among researchers and public health 
specialists. A particular focus has been on old-age 
mortality and its relationship to the policy of fiscal 
austerity pursued by UK governments since 2010.9,10 
However, less attention has been given to the adverse 
mortality trends at younger ages, even though several 
analyses have shown increases since 2010 in all-cause 
mortality in adults younger than 50 years in England11 
and other parts of the UK.7
Several reports have shown that the UK is not alone in 
showing reductions in the rate of increase of life 
expectancy.5,12 A 2019 report by the Organisation for 
Economic Co-operation and Development12 showed that 
life expectancy improvements in most EU countries over 
the period 2011–16 were slower than in the preceding 
5 years, 2006–11, although the deceleration in the UK was 
the largest. Such geographical and temporal 
contextualisation sheds new light on the challenges faced 
by the UK and helps to identify priority areas for 
intervention.12–14
We aimed to examine how life expectancy and mortality 
rates in England and Wales have evolved since 1970 
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relative to a set of other high-income countries. We paid 
particular attention to differences between men and 
women and distinctive age patterns.
Methods
Populations, timepoints, and sources
We used annual mortality data (1970–2016) from the 
Human Mortality Database (HMD),15 which applies 
comprehensive and uniform methods to ensure high-
quality mortality estimates at all ages that are comparable 
across time and between countries. Of the available 
HMD countries, we selected those that we considered 
as high-income peers of England and Wales. These 
countries have low mortality and had undergone 
substantial and steady improvements in life expectancy 
over the past 50 years or more, and had complete annual 
time series data available for 1970–2016. Our comparitor 
group of countries comprised 15 countries from wester 
Europe, plus Australia, Canada, New Zealand, Japan, and 
the USA (figure 1). We also included Scotland as a 
separate population because of the country’s higher 
mortality rates than in England and Wales,16 making a 
total of 22 countries.
Statistical analysis and visualisation
We used median life expectancy and mortality rates for 
all 22 comparator countries to express the central 
tendency for this group. The median is less sensitive 
than mean values to random fluctuations of life 
expectancy and mortality that occur in small countries 
(eg, Iceland). For each year, the median death rate at 
every age was calculated as the median of death rates 
across all countries at the same age. In the same way, we 
computed the upper and the lower quintile death rates 
for every age. These median and quantile age-specific 
death rates were then used to calculate life tables and life 
expectancy at birth for the median, the upper, and the 
lower 20% levels.
To visualise the long-term evolution of differences in 
life expectancy in England and Wales relative to the other 
countries between 1970 and 2016, we plotted the annual 
life expectancy for England and Wales and each of the 
other 22 countries for men and women separately. These 
life expectancies were then overlaid with the annual 
median and the top and bottom quintiles (upper 20th and 
lower 20th percentiles) for the 22 comparator countries. 
For every year from 1970 to 2016, we calculated the ratio 
of the total mortality rates in each 1-year age group in 
England and Wales to the median of the comparator 
countries.
Finally, focusing on the trends that have occurred in 
the most recent years, we separated the differences in 
life expectancy between England and Wales and the 
22-country median for the periods 2001–06, 2006–11, and 
2011–16 into two components. The first component 
shows the absolute contribution in years of life expectancy 
of differences in trends over each 5-year period broken 
down by broad age groups. The second component 
isolates the contribution of the differences between 
England and Wales and the 22-country median at the end 
of each period that was attributable to differences seen at 
the start of the interval, using the method of contour 
decomposition of differences between life expectancies.17 
For example, for a life expectancy difference between 
two populations of 1·5 years in 2016, the contour 
decomposition method might show that 0·8 of the 
Research in context
Evidence before this study
Since 2011, the long-term trend in the increase of life 
expectancy in England and the rest of the UK has faltered. 
Previous analyses of this issue have tended to emphasise the 
effect on old age mortality of the austerity policy pursued by 
the UK Government over the past decade. The UK is not alone in 
showing some degree of deacceleration in life expectancy 
progression in the most recent period. We searched PubMed, 
without time restrictions, using the terms (“England” or 
“United Kingdom”) and (“life expectancy”) and (“trends”) or 
(“stalling” or “decline”). Given our objectives, we focused 
primarily, but not exclusively, on material published between 
2010 and 2019. 
Added value of this study
We placed these trends in the context of what has happened in 
a group of other high-income countries over the longer term 
since 1970. Until 2010, male life expectancy in England and 
Wales was unremarkable and tracked the median value for a set 
of 22 comparator countries. By contrast, female life expectancy 
has not progressed as well as it has in other countries since the 
mid-1970s, largely because of the relative timing of the 
smoking epidemic. However, for both sexes since 2011, 
the deficit in life expectancy has grown between England and 
Wales and the median of the comparator countries, which is 
unlikely to be due to chance. This deficit was due to divergence 
in mortality among working-age and older adults between 
England and Wales and the other countries. A new 
phenomenon has emerged since the mid-2000s whereby 
mortality in young and middle-aged men and women is now 
appreciably higher than in the 22-country comparison group.
Implications of all the available evidence
High-income countries as a group have struggled to maintain 
the rates of life expectancy improvement. The UK has in the 
most recent period shown particularly small improvements. 
However, whether this performance will persist into the future 
is unclear. Particular attention must be paid to understanding 
why mortality rates in young and middle-aged adults in 
England and Wales are diverging from those of their peers 
elsewhere.
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1·5 years are due to the initial mortality difference in 
2011, and 0·7 years are due to a steeper mortality decrease 
in one population relative to that in the other. These 
0·7 years can be further split by age so that 0·3 years are 
produced by mortality trends in people younger than 
65 years, and 0·4 years could be caused by mortality 
trends in people older than 65 years. Further details 
about this method are provided in the appendix (pp 1–2).
Role of the funding source
This study was done without specific funding. The 
corresponding author had full access to all the data in the 
study and had final responsibility for the decision to 
submit for publication.
Results
Figure 1 shows the trends in life expectancy at birth 
from 1970 to 2016 for men and women for England and 
Wales and the 22 comparator countries. Male life 
expectancy at birth in England and Wales followed the 
median almost exactly apart from in the late 1970s and 
in 2011–16, and occupied between the 10th and 12th rank 
positions up until the end of the 2000s, from which 
point it was between the 11th and 14th positions.
Female life expectancy in England and Wale was at the 
median level of the 22 comparator countries in 1970. 
However, from that point until the mid-1980s, female 
life expectancy, relative to the median, deteriorated 
considerably, with a fall in rank position from 9th to 18th. 
Since then, female life expectancy in England and Wales 
has followed the bottom quintile of the distribution, and 
in the years 2014–16 was ranked 20th.
The average annual increases in life expectancy in 
consecutive 5-year periods starting in 1971–76 to 2011–16 
for England and Wales and the 22-country median are 
shown in table 1. 2011–16 showed the smallest increase 
for the 22-country median and England and Wales. The 
life expectancy increase in England and Wales was 
particularly small. This finding contrasts with the rate of 
improvement in the previous period (2006–11) that was 
the largest for England and Wales for both sexes (table 1).
To assess whether the divergence in the rate of 
improvement between England and Wales and the 
median mortality based on the 22 comparator countries 
was larger than might be expected by chance given the 
year-by-year fluctuations, we regressed the annual 
difference between the two life expectancies by year over 
the period 1996–2011. We projected this trend forward to 
2016 with its 95% CI. For 2015 and 2016, for both sexes 
the observed difference between England and Wales and 
the 22-country median fell below the lower 95% CI, 
suggesting that the larger slowdown in England and 
Wales compared with other countries is unlikely to be 
due to chance (appendix pp 3–4).
Figure 2 shows the mortality rates in each 1-year 
age group in England and Wales as a ratio to 
the corresponding median mortality rates for the 
22 comparator countries. We found a diagonal pattern of 
higher male mortality at age 50 years and older in England 
and Wales relative to the 22-country median. We found a 
Figure 1: Life expectancy at birth in 23 high-income countries and regions, plus the (cross-country) median life expectancy and the lower and the upper 
median life expectancy quintiles for the comparator group of 22 countries, 1970–2016
Countries included are Australia, Austria, Belgium, Canada, Denmark, England and Wales, Finland, France, Germany, Iceland, Ireland, Italy, Japan, Luxembourg, 
the Netherlands, New Zealand, Norway, Portugal, Scotland, Spain, Sweden, Switzerland, and the USA. Median and upper and lower quintile values are shown as open 
circles. A spreadsheet of the data on which this figure is based are provided in the appendix (p 4).
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similar, even more pronounced, diagonal pattern for 
women, although the pattern is displaced down and to 
the right compared to men (figure 2). The diagonal dotted 
line indicates the birth cohort of 1900 for men and 
1925 for women, which were the cohorts that smoked 
most in the UK, as supported by the fact that men and 
women born around these dates have had the highest 
lung cancer mortality of any birth cohorts.18
We found a simultaneous emergence in men and 
women from the mid-2000s of excess mortality among 
those aged 25–50 years in England and Wales relative to 
the 22-country median, as delineated by a continuous 
white line (figure 2). This finding is particularly striking 
for men because in the preceding years up to the mid-
1990s, mortality was lower than in the 22-country median 
in men younger than 40 years (figure 2).
The effect of the negative trend in working-age mortality 
in England and Wales on differences in life expectancy 
relative to the 22-country median is shown in table 2. In 
2016, the life expectancy disadvantage of England and 
Wales was −0·34 years for men and −1·00 years for 
women (table 2). In 2011, male life expectancy in England 
and Wales was 0·25 years higher than the comparator 
Male Female
England and Wales 22-country median England and Wales 22-country median
1971–76 0·10 0·21 0·07 0·26
1976–81 0·27 0·32 0·24 0·27
1981–86 0·19 0·22 0·15 0·20
1986–91 0·25 0·21 0·19 0·15
1991–96 0·24 0·23 0·16 0·16
1996–2001 0·30 0·31 0·20 0·21
2001–06 0·29 0·30 0·22 0·21
2006–11 0·33 0·31 0·25 0·14
2011–16 0·07 0·18 0·02 0·13
Table 1: Mean annual change (years) in life expectancy at birth for England and Wales and the median of 
22 countries by sex, 1971–2016
Figure 2: Mortality rate ratios in England and Wales relative to the median for 22 comparator countries by age, year, and sex
Figure shows the ratio of the total mortality rates in each 1-year age group in England and Wales to the median of the comparator countries. The white dashed lines 
correspond to the 1900 male birth cohort and the 1925 female birth cohort. The white continuous lines delineate the area of emerging mortality excess in England 
and Wales relative to the 22-country median.
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median, whereas for women there was a deficit of 
−0.41 years (table 2). The results of the contour 
decomposition (table 3) show the age-specific contribution 
of trends to the changes in life expectancy in each period. 
In the period 2011–16, the overall contribution of adverse 
trends was the same in both sexes (−0·60 years). All age 
groups, except boys aged 0–14 years, contributed to this 
negative trend. Adverse contributions at working ages 
(15–64 years) were slightly larger for men (−0·34 years) 
than for women (−0·25 years). Trends in people aged 
65 years and older made similar sized contributions to 
these younger ages, and were similar for men 
(−0·29 years) and women (−0·33 years), although for 
women the contribution in those aged 80 years or older 
was particularly notable (−0·28 years).
Table 3 shows that the negative trend component seen 
in all adult age groups for 2011–16 was preceded in 
2006–11 by positive trends in every age group except 
those aged 35–49 years. This finding is similar to that 
with respect to overall trends in life expectancy in the two 
most recent 5-year periods (table 1).
To check the robustness of our findings we repeated all 
analyses using means for the comparator countries 
rather than median values. These analyses were done in 
an equivalent way by taking the mean rather than 
the median and upper and lower fifths of age-specific 
mortality rates in each year for the 22 comparator 
countries. The substantive findings were not altered. We 
present figures and tables based on the estimated 
22-country means rather than medians in the 
appendix (pp 5–8).
Discussion
Our analyses have uncovered several important and 
overlooked aspects of trends in life expectancy in England 
and Wales relative to those of our comparison group of 
22 high-income countries. Firstly, throughout most of 
the period since 1970, male life expectancy in England 
and Wales followed the median central tendency of the 
comparator group. By contrast, since the mid-1970s, 
female life expectancy in England and Wales has been 
lower than in most other countries. Secondly, focusing 
on the past decade, a general slowdown in life expectancy 
improvement has occurred across many countries. 
However, during the period 2011–16, the slowdown was 
steeper in England and Wales than in many other 
countries, driven by diverging mortality rates at every 
adult age. Thirdly, and most surprisingly, since the mid-
2000s, a new and worrying pattern has emerged of higher 
mortality rates among men and women aged 25–50 years 
in England and Wales compared with other countries.
To our knowledge, our analyses are the first to show 
that whereas male life expectancy in England and Wales 
between 1970 and 2010 was unexceptional, following 
almost exactly the median of the 22 countries analysed, 
female life expectancy in England and Wales compared 
poorly with other countries from the mid-1970s onwards. 
This finding is despite the fact that since the mid-1990s, 
the gap in female life expectancy between England and 
Wales and the 22-country median narrowed in absolute 
terms until 2011.
A comprehensive analysis of factors that are likely to 
explain the long-term trajectory in life expectancy of 
England and Wales relative to the comparator group of 
countries was beyond the scope of this study. Ideally, we 
would have looked at comparable and comprehensive 
data for all the countries to examine long-term trends in 
many factors such as smoking, diet, exercise, obesity, 
alcohol, and the performance of the health-care systems. 
However, such data were available for only a small 
proportion of the countries we considered.
Our results suggest that smoking is likely to be one of 
the explanations for the long-term, relatively poor increase 
in female life expectancy in England and Wales from the 
early 1970s onwards. The UK was in the vanguard of the 
cigarette epidemic for men and women,19,20 although 
consistent with the diffusion model of smoking dynamics 
in the population, women started later than men.21 
Indirect estimates of the con-tribution of smoking to total 
mortality by country in 1955, 1980, and 2009, support our 
contention that this factor is important for explaining the 
position of England and Wales (and Scotland) over the 
long term.22
For women, from the early 1970s, England and Wales 
showed increasingly divergent mortality rates compared 
with the 22-country median, as shown by the diagonal 
Male Female
2001 2006 2011 2016 2001 2006 2011 2016
England and Wales 75·95 77·38 79·04 79·40 80·58 81·66 82·91 83·02
22-country median 75·97 77·61 78·79 79·74 81·52 82·52 83·32 84·03
Difference in life 
expectancy (years)
–0·02 –0·23 0·25 –0·34 –0·94 –0·86 –0·41 –1·00
Table 2: Comparison of life expectancy at birth (years) in England and Wales and median for 
22 comparator countries in selected years, 2001–16
Male Female
2001–06 2006–11 2011–16 2001–06 2006–11 2011–16
Age group (years)
0–14 –0·09 0·02 0·04 –0·08 0·08 –0·02
15–34 –0·11 0·05 –0·11 –0·01 0·02 –0·05
35–49 –0·13 –0·05 –0·09 –0·03 –0·02 –0·08
50–64 –0·01 0·07 –0·14 0·10 0·03 –0·12
65–79 0·10 0·19 –0·15 0·13 0·23 –0·05
≥80 0·04 0·29 –0·14 0·02 0·16 –0·28
All ages –0·19 0·50 –0·60 0·13 0·50 –0·60
Component of life expectancy 
differences due to differences in 
initial year of period
–0·04 –0·25 0·26 –0·99 –0·90 –0·40
Table 3: Contribution of trends by age group and initial values to differences between life expectancy in 
England and Wales and the median for 22 countries for selected 5-year periods, 2001–16 
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pattern centred on women born around 1925, who 
smoked more than other UK cohorts did before or 
subsequently (figure 2).18,23,24 We contend that this pattern 
exists because the UK was among the leaders of the 
global smoking epidemic. Many women in the UK took 
up smoking earlier in the 20th century and smoked more 
heavily than did women in most other countries. 
Smoking probably has less influence in explaining the 
relative mortality patterns of men in England and Wales 
in the period that we analysed. Although the birth cohort 
differences in how various countries took up smoking 
are also evident for men in figure 2, these differences are 
not as intense as for women, with the peak of the 
mortality effects of the early UK male smoking epidemic 
having already passed by the 1970s.
One of our most striking findings is that between 1970 
and the mid-1990s, men younger than 45 years had 
persistently lower mortality than the 22-country median. A 
similar but less pronounced relative advantage is apparent 
in young adult women until the 1990s. This finding is 
partly explained by the UK having had particularly low 
mortality rates from external causes compared with other 
countries.25 According to the Health for All database,26 
between the 1970s and the 1990s, the age-standardised 
death rates for external causes of injury, poisoning, and 
violence among people younger than 65 years were 
30–35% lower than the average of the 15 members of the 
EU in May 2004 (EU15), before the accession of eastern 
European states. However, between 2001 and 2009, this 
advantage gradually disappeared, with rates in the UK 
going from being 28% to 18% lower. In the 2010s, this 
advantage was almost eliminated, being only 1% lower 
than that of the EU15 average by 2015.26
The 23 countries in this study include many with some 
of the highest life expectancies in the world. In these 
countries, progress in female life expectancy is slower 
than for male life expectancy because it is increasing 
dependent upon overcoming the major challenge of 
reducing mortality at old and very old age, with 
diminished scope for reductions at younger ages, where 
much has already been achieved.27
Our analyses confirm earlier observations9 of a 
plateauing of life expectancy in England and Wales in the 
period 2011–16. However, as others have found,5,12 we also 
showed that the rate of progress has declined for 
many other countries in the same period, albeit less 
dramatically. Our analysis has gone further than those in 
previous work in showing that since 2011, life expectancy 
has progressively diverged in England and Wales com- 
pared with other high-income countries as a group, and 
that this finding is unlikely to be due to chance. The low 
rate of improvement in 2011–16 in England and Wales was 
preceded by a 5-year interval (2006–11) with the largest 
annual improvements for England and Wales throughout 
the entire period covered by this study for both sexes. 
Moreover, these increases were much larger than for the 
22-country median, mainly because of divergent trends in 
those older than 65 years. This extended period of 
atypically low mortality at older ages in England and Wales 
could have led to the survival of a subset of frail individuals 
whose death then occurred in the subsequent years, 
particularly with the notable increase in winter mortality 
linked to influenza in 2014–15.28
The deficit of life expectancy at birth in England and 
Wales compared with the 22-country median was larger in 
2016 than in 2001, 2006, or 2011 because in the period 
2011–16, in every adult age group, mortality diverged 
between England and Wales and the 22-country median. 
However, starting in the mid-2000s, at ages 25–50 years 
in men and women, a new and pronounced excess 
mortality has emerged in England and Wales relative to the 
22-country median. Mortality divergence at ages 
15–49 years contributed 33% for males and 22% for 
females to the enlargements of the life expectancy gaps (in 
2011–16) between England and Wales and the comparator 
median. Although these contributions are lower in abso-
lute terms than those at ages 65 years and older, this 
finding is concerning. A similar finding among adults 
aged 15–40 years was previously observed in an analysis of 
Scottish mortality until 2010, relative to the rest of the UK 
and western Europe.29
To understand this new phenomenon, an analysis by 
cause of death would be helpful. Unfortunately, for the 
period 2011–16, fully comparable and complete data on 
cause-specific observed mortality rates are not available 
for several of the 23 countries we have analysed. However, 
relative to the EU15 countries, in the most recent years 
the previous UK advantage in external cause mortality 
has been almost eliminated since 2010.
Analyses of age-specific and cause-specific trends in 
mortality in the UK throughout this period have been 
reported by others. A notable growth in regional 
disparities in England since the 1990s among people 
aged 25–44 years has been seen, attributable to sharp 
rises in deaths from cardiovascular causes, alcohol 
misuse, and drug misuse in the north compared with the 
south.30 Other analyses have shown that from the late-
2000s to 2016 mortality increased from all causes among 
people aged 30–34 and 40–49 years in England, with 
those aged 30–34 years showing the largest percentage 
increase (8%) of any age group.31 Mortality rates from 
external causes in adults aged 35–54 years in England, 
Wales, Scotland, and Northern Ireland have similarly 
increased over this period.7 However, without comparative 
data for the other 22 countries, we cannot know with 
certainty which causes have resulted in the increasing 
disparity with other countries in this age group.
How far the relative excess of mortality among working-
age adults in England and Wales is transient is impossible 
to anticipate because the causes are unclear. One parallel 
is with what has happened in the USA. A 2013 study 
found that high US mortality among people younger than 
50 years relative to people from a group of comparator 
countries accounted for two-thirds of the gap in male life 
Articles
www.thelancet.com/public-health   Vol 4   November 2019 e581
expectancy and two-fifths of the female gap.32 This 
mortality problem in this age group in the USA is at least 
partly driven by a combination of socioeconomic 
deprivation and a major problem of misuse of medicinal 
opioids.33 However, although drug-related deaths in 
England and Wales have increased,34 to date the increase 
has been on a smaller scale.33 Further research to 
understand why adult mortality rates in England and 
Wales at working age and older ages are faltering relative 
to many other countries must be prioritised.
Much of the debate around the plateauing of life 
expectancy in the UK has focused upon the possible 
contribution of the UK Government’s policy of austerity.35,36 
Resources for the National Health Service and social care 
for older and susceptible people have been under 
increasing pressure in the past decade. However, the fact 
that there has been a slowdown in improvements in many 
countries suggests that at least part of the phenomenon is 
not the result of specific and unique UK Government 
policies and health and welfare spending. The health-care 
budgets of at least some of the comparator countries have 
also been constrained, which might partly explain the 
general tendency observed. We were unable to address 
this issue with the data we had available. Additionally, our 
results suggest that the adverse relative trends are driven 
equally by problems among people of working ages and 
not just among older people. Certainly, the emergence 
over the past 15–20 years of excess mortality in adults 
younger than 50 years in England and Wales relative to the 
22-country median deserves further investigation.
UK Government policy has resulted in considerably 
increased hardship and poverty for many adults, children, 
and families,37 which is additional to any effect of reduced 
government spending on the health sector per se.36 
Socioeconomic differences in mortality and life 
expectancy in the UK are widening.38 A report showed 
that life expectancy in England and Wales in 2016–17 
declined among women compared with in 2012–14 for 
the 30% of the population living in the most deprived 
areas, whereas life expectancy increased among those 
who were living in the least deprived areas.39 For men, the 
most deprived areas did not show any improvement, 
whereas for those living in the least deprived areas, life 
expectancy continued to increase. This finding indicates 
that whatever the drivers are for the faltering in life 
expectancy in England and Wales, such causes are having 
an unequal effect on different sections of the population.
One factor that will influence the position of England 
and Wales compared with other high-income countries is 
the relative timing of the mortality effects of the smoking 
epidemic in other countries. For men and women in the 
UK the peak of the mortality effects of the epidemic has 
now passed, and thus will no longer have such a 
constraining effect on mortality improvements in 
England and Wales relative to other countries.
From a broader perspective, as populations age, 
progress in life expectancy becomes more difficult over 
time because improvement depends increasingly on 
mortality reduction in old age. Nevertheless, exceptions 
exist. Life expectancy trends in 2011–16 have not slowed 
down in Italy, Japan, New Zealand, Norway, and 
Switzerland. These countries had higher life expectancies 
in 2011 than did England and Wales. Also, life expectancy 
continues to rise in highly educated groups, who have 
higher life expectancies than does any national 
population.40 Thus, regardless of what the upper biological 
limit to longevity might be,41 these leading populations 
show that a substantial amount of lifetime is still to be 
gained for people in the UK and most other countries 
before they approach the limit.
Finally, this fairly optimistic outlook assumes that the 
configuration of economic and social forces that have 
operated since the middle of the 20th century, that have 
generally facilitated the advances in life expectancy, will 
not be undermined. Such stability is not a given, with the 
world facing major challenges, from climate change to 
the disruption of long-established aspects of international 
collaboration and cooperation, many of which have been 
important for progress in health.
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